Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2017 Filed Jun 26, 2018 20:59 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000363 · primary_doc.xml · derivative · entry 11 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F11 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jun 26, 2018 20:26 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000362 · primary_doc.xml · derivative · entry 20 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F20 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. This option vests on December 1, 2018. F20 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. This option vests on December 1, 2018. F20 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. This option vests on December 1, 2018. F20 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. This option vests on December 1, 2018. F20 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. This option vests on December 1, 2018. F20 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. This option vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jun 26, 2018 19:20 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000361 · primary_doc.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F11 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F11 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jun 26, 2018 17:12 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000360 · primary_doc.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F9 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jul 2, 2018 22:33 UTC |
Sill Garrett S.CFO; Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,750 | $4.80 Strike: $4.80 | $75,600.00 |
DisclosureSEC source: 0001096906-18-000374 · primary_doc.xml · derivative · entry 7 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Class C Common Stock · 15,750 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Jul 2, 2018 21:38 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $4.80 Strike: $4.80 | $25,200.00 |
DisclosureSEC source: 0001096906-18-000373 · primary_doc.xml · derivative · entry 7 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F8 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F8 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F8 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. Read SEC document |
| December 01, 2017 Filed Jul 3, 2018 19:58 UTC |
Johnson Stephen CharlesVP Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,500 | $4.80 Strike: $4.80 | $50,400.00 |
DisclosureSEC source: 0001096906-18-000376 · primary_doc.xml · derivative · entry 8 Johnson Stephen Charles · CIK 0001661597 · VP Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Underlying: Class A Common Stock · 10,500 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · balance_after: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. Read SEC document |
| December 01, 2017 Filed Jul 3, 2018 16:28 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,000 | $4.80 Strike: $4.80 | $100,800.00 |
DisclosureSEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 8 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Class C Common Stock · 21,000 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Jul 5, 2018 16:18 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $4.80 Strike: $4.80 | $25,200.00 |
DisclosureSEC source: 0001096906-18-000378 · primary_doc.xml · derivative · entry 8 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. F9 · balance_after: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested. Read SEC document |
| December 01, 2017 Filed Jul 5, 2018 15:28 UTC |
Quist S. AndrewDirector · VP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,000 | $4.80 Strike: $4.80 | $100,800.00 |
DisclosureSEC source: 0001096906-18-000377 · primary_doc.xml · derivative · entry 8 Quist S. Andrew · CIK 0001588309 · Director · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Class C Common Stock · 21,000 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018. F9 · shares: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018. F9 · price: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018. F9 · derivative.exercise_date: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018. F9 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018. F9 · balance_after: This option was granted on December 2, 2016 as an option for 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018. Read SEC document |
| December 01, 2017 Filed Jul 18, 2018 19:48 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 78,750 | $5.28 Strike: $5.28 | $415,800.00 |
DisclosureSEC source: 0001096906-18-000395 · primary_doc.xml · derivative · entry 7 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Class A Common Stock · 78,750 shares Expires 2022-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share. The option vests in four quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share. The option vests in four quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share. The option vests in four quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share. The option vests in four quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share. The option vests in four quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share. The option vests in four quarterly installments of Class A Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Jul 18, 2018 16:09 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000394 · primary_doc.xml · derivative · entry 11 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F10 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F10 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F10 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F10 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F10 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F10 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Oct 31, 2018 21:23 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000608 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F8 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F8 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F8 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Dec 3, 2018 16:56 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $4.80 Strike: $4.80 | $25,200.00 |
DisclosureSEC source: 0001096906-18-000678 · primary_doc.xml · derivative · entry 8 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018 F7 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018 F7 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018 F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018 F7 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018 Read SEC document |
| December 01, 2017 Filed Dec 31, 2018 22:32 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000705 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Dec 31, 2018 21:44 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000704 · primary_doc.xml · derivative · entry 19 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F19 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. F19 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. F19 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. F19 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. F19 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Dec 31, 2018 20:50 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.79 Strike: $4.79 | $5,029.50 |
DisclosureSEC source: 0001096906-18-000703 · primary_doc.xml · derivative · entry 17 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F17 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F17 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F17 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F17 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F17 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Dec 31, 2018 19:57 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-18-000702 · primary_doc.xml · derivative · entry 10 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F10 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F10 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F10 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F10 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F10 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Dec 31, 2018 19:19 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,000 | $4.80 Strike: $4.80 | $100,800.00 |
DisclosureSEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 6 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Class C Common Stock · 21,000 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Dec 31, 2018 18:52 UTC |
Sill Garrett S.CFO; Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,750 | $4.80 Strike: $4.80 | $75,600.00 |
DisclosureSEC source: 0001096906-18-000700 · primary_doc.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Class C Common Stock · 15,750 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jan 2, 2019 17:12 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $4.80 Strike: $4.80 | $25,200.00 |
DisclosureSEC source: 0001096906-19-000002 · primary_doc.xml · derivative · entry 7 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · balance_after: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jan 2, 2019 16:44 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-19-000001 · primary_doc.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Jan 3, 2019 22:43 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $4.80 Strike: $4.80 | $25,200.00 |
DisclosureSEC source: 0001096906-19-000003 · primary_doc.xml · derivative · entry 5 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2027-12-01 F5 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018. F5 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018. F5 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018. F5 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018. F5 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option fully vests on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jan 10, 2019 21:45 UTC |
Quist S. AndrewDirector · VP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,000 | $4.80 Strike: $4.80 | $100,800.00 |
DisclosureSEC source: 0001096906-19-000013 · primary_doc.xml · derivative · entry 7 Quist S. Andrew · CIK 0001588309 · Director · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Class C Common Stock · 21,000 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F7 · balance_after: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jan 22, 2019 21:17 UTC |
Quist Adam GeorgeVP & General Counsel
|
ConversionEmployee Stock Option (right to buy) · Derivative | 15,750 | $4.80 Strike: $4.80 | $75,600.00 |
DisclosureSEC source: 0001096906-19-000031 · primary_doc.xml · derivative · entry 4 Quist Adam George · CIK 0001740330 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Class C Common Stock · 15,750 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F4 · shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F4 · price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F4 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F4 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jan 22, 2019 20:42 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 78,750 | $5.28 Strike: $5.28 | $415,800.00 |
DisclosureSEC source: 0001096906-19-000030 · primary_doc.xml · derivative · entry 6 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Class A Common Stock · 78,750 shares Expires 2022-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. F6 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018. Read SEC document |
| December 01, 2017 Filed Jan 30, 2019 16:43 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $4.80 Strike: $4.80 | $5,040.00 |
DisclosureSEC source: 0001096906-19-000044 · primary_doc.xml · derivative · entry 10 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. Read SEC document |
| December 01, 2017 Filed Feb 4, 2019 21:33 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000053 · primary_doc.xml · derivative · entry 9 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 5, 2019 17:25 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000054 · primary_doc.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F11 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F11 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F11 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F11 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F11 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 6, 2019 17:03 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000055 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 11, 2019 23:32 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,513 | $4.56 Strike: $4.56 | $25,139.28 |
DisclosureSEC source: 0001096906-19-000059 · primary_doc.xml · derivative · entry 6 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2027-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 11, 2019 23:06 UTC |
Sill Garrett S.CFO; Treasurer
|
PurchaseEmployee Stock Option (right to buy) · Derivative | 16,538 | $4.56 Strike: $4.56 | $75,413.28 |
DisclosureSEC source: 0001096906-19-000058 · primary_doc.xml · derivative · entry 7 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,538 Underlying: Class C Common Stock · 16,538 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 13, 2019 18:26 UTC |
Quist S. AndrewDirector · VP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.56 Strike: $4.56 | $100,548.00 |
DisclosureSEC source: 0001096906-19-000063 · primary_doc.xml · derivative · entry 8 Quist S. Andrew · CIK 0001588309 · Director · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · price: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · balance_after: This option was granted on December 1, 2017 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 20, 2019 20:23 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,513 | $4.56 Strike: $4.56 | $25,139.28 |
DisclosureSEC source: 0001096906-19-000073 · primary_doc.xml · derivative · entry 8 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · price: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · balance_after: This option was granted on December 1, 2017 as an option for 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 21, 2019 21:14 UTC |
Johnson Stephen CharlesVP Mortgage Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 11,025 | $4.56 Strike: $4.56 | $50,274.00 |
DisclosureSEC source: 0001096906-19-000074 · primary_doc.xml · derivative · entry 8 Johnson Stephen Charles · CIK 0001661597 · VP Mortgage Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,025 Underlying: Class A Common Stock · 11,025 shares Expires 2027-12-01 F9 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · price: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.exercise_date: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F9 · balance_after: This option was granted on December 1, 2017 as an option for 10,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions in the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 22, 2019 21:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000077 · primary_doc.xml · derivative · entry 18 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F18 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 22, 2019 21:57 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 82,688 | $5.02 Strike: $5.02 | $415,093.76 |
DisclosureSEC source: 0001096906-19-000078 · primary_doc.xml · derivative · entry 6 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Class A Common Stock · 82,688 shares Expires 2022-12-01 F7 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F7 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 22, 2019 18:53 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000076 · primary_doc.xml · derivative · entry 18 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F18 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F18 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 22, 2019 17:51 UTC |
Quist Adam GeorgeVP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 16,538 | $4.56 Strike: $4.56 | $75,413.28 |
DisclosureSEC source: 0001096906-19-000075 · primary_doc.xml · derivative · entry 5 Quist Adam George · CIK 0001740330 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,538 Underlying: Class C Common Stock · 16,538 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Feb 25, 2019 16:47 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,050 | $4.56 Strike: $4.56 | $100,548.00 |
DisclosureSEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 7 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Class C Common Stock · 22,050 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Apr 19, 2019 23:02 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000148 · primary_doc.xml · derivative · entry 11 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed May 22, 2019 19:07 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,513 | $4.56 Strike: $4.56 | $25,139.28 |
DisclosureSEC source: 0001096906-19-000216 · primary_doc.xml · derivative · entry 7 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Jul 8, 2019 20:35 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantDirector Stock Option (right to buy) · Derivative | 82,688 | $5.02 Strike: $5.02 | $415,093.76 |
DisclosureSEC source: 0001096906-19-000256 · primary_doc.xml · derivative · entry 6 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Class A Common Stock · 82,688 shares Expires 2022-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Aug 1, 2019 17:36 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 82,688 | $5.02 Strike: $5.02 | $415,093.76 |
DisclosureSEC source: 0001096906-19-000271 · primary_doc.xml · derivative · entry 8 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Class A Common Stock · 82,688 shares Expires 2022-12-01 F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · price: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F8 · balance_after: This option was granted on December 1, 2017 as an option for 75,000 shares of Class A Common Stock at an exercise price of $5.56 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Sep 27, 2019 17:39 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000338 · primary_doc.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Nov 22, 2019 17:46 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000396 · primary_doc.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 13, 2019 16:44 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000413 · primary_doc.xml · derivative · entry 6 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 17, 2019 18:42 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000423 · primary_doc.xml · derivative · entry 17 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F17 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 17, 2019 20:19 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.56 Strike: $4.56 | $5,029.68 |
DisclosureSEC source: 0001096906-19-000427 · primary_doc.xml · derivative · entry 19 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2027-12-01 F17 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · price: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F17 · balance_after: This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
| December 01, 2017 Filed Dec 17, 2019 21:37 UTC |
Sill Garrett S.CFO; Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 16,538 | $4.56 Strike: $4.56 | $75,413.28 |
DisclosureSEC source: 0001096906-19-000429 · primary_doc.xml · derivative · entry 6 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,538 Underlying: Class C Common Stock · 16,538 shares Expires 2027-12-01 F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · price: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. F6 · balance_after: This option was granted on December 1, 2017 as an option for either 15,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 15,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.